Wearable Healthcare Devices Market: Major Players and Growth Opportunities

-

The global wearable healthcare devices market is projected to reach USD 30.1 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 13.2% during the forecast period. Growth in the wearable healthcare devices market is mainly driven by factors such as the development of technologically advanced products and growing geriatric population and subsequent increase in the incidence of chronic diseases. However, patent protection of wearable healthcare devices and limited battery life are the major factors hampering the growth of this market.

The major players in this market are Koninklijke Philips N.V. (Netherlands), Apple Inc. (US), GE Healthcare (US), Fitbit Inc. (US), Abbott Laboratories (US), OMRON Corporation (Japan), Garmin Ltd. (US), Dexcom Inc. (US), Masimo Corporation (US), Medtronic PLC (Ireland), BioTelemetry Inc. (US), Preventice Solutions Inc. (US), iRhythm Technologies Inc. (US), Contec Medical Systems Co. Ltd. (China), MediBioSense Ltd. (UK), VitalConnect (US), Cyrcadia Health Inc. (US), Ten3T Healthcare (India), Verily Life Sciences (US), MinttiHealth (China), Bio-Beat (Israel), Biotricity Inc. (US), iHealth Lab Inc. (US), Vivalink (US), Gentag (US).

Apple, Inc. held the leading position in the wearable healthcare devices market in 2020. The company maintains its leading position in this market through its strong global sales and distribution network. The company adopts organic growth and inorganic growth strategies to increase its dominance in this market. It also focuses on product approvals to complement its existing business segments.

In 2020, Apple held the second position in the wearable healthcare devices market. The company has maintained its leading position through its strong distribution networks across North America, Europe, and other developed countries. The company adopts organic growth strategies to increase its dominance in this market. It also focuses on product launches to complement its existing business segments.

Koninklijke Philips N.V. held the leading position in the wearable healthcare devices market in 2020. The company maintains its leading position in this market through its strong global sales and distribution network. The company adopts organic and inorganic growth strategies to increase its dominance in this market. It also focuses on product launches to complement its existing business segments.

Driver: Increasing awareness of fitness, lifestyle, and home healthcare

The wearable healthcare devices market has witnessed significant growth in recent years, primarily due to the rising geriatric population, the increasing prevalence of chronic diseases, and the availability of advanced medical devices (including wearable medical devices) that enable the delivery of quality care in non-hospital settings.
Opportunity: Increasing adoption of artificial intelligence and 5G

5G, artificial intelligence (AI), and machine learning (ML) can be used to determine potential diagnoses and treatments for a specific patient. Furthermore, AI can help predict which patients are more likely to have postoperative complications, allowing healthcare systems to provide early interventions. Generally, real-time learning with a high volume of data needs trustworthy and high-bandwidth networks. With the help of 5G networks, healthcare organisations can use AI tools to provide the best care possible in real-time, wherever they are. Thus, the use of emerging advanced tools and technologies like AI and 5G can be expected to provide high-growth opportunities in the wearable healthcare devices market.

Related Links:

https://www.marketsandmarkets.com/Market-Reports/wearable-medical-device-market-81753973.html

https://www.marketsandmarkets.com/PressReleases/wearable-medical-device.asp

https://www.marketsandmarkets.com/ResearchInsight/wearable-medical-device-market.asp

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more